title: [Objectivity in research in the pharmaceutical industry is possible].
abstract: A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain objective in its research activities. This paper discusses the prerequisites for objective research and to what extent these are met by research projects conducted by the pharmaceutical industry. Problems with meeting objectivity criteria on the part of the pharmaceutical industry will be highlighted, distinguishing between industrial research activities themselves (i.e., studies) and the publication of data resulting from such research. The aim of the discussion is to illustrate how and which research-guiding conditions can ensure that sponsors indeed meet the criteria for objective research.
authors.affiliation: Janssen-Cilag GmbH, Johnson & Johnson Platz 1, 41470 Neuss. ktorfs1@its.jnj.com
authors.forename: Koen
authors.initials: K
authors.lastname: Torfs
authors.forename: Ina
authors.initials: I
authors.lastname: Rudolph
authors.forename: Angelika
authors.initials: A
authors.lastname: Mehnert
authors.forename: Jörn
authors.initials: J
authors.lastname: Sindern
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards; D004345:Drug Industry / Q000941:ethics* / Q000592:standards*; D004358:Drug Therapy / Q000592:standards; D032984:Ethics, Research; D005858:Germany; D006801:Humans; D011643:Publishing / Q000592:standards; D012106:Research / Q000592:standards*